Martingale Asset Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-83,038
| Closed | -$229K | – | 855 |
|
|
2025
Q1 | $229K | Sell |
83,038
-15,068
| -15% | -$41.6K | 0.01% | 723 |
|
|
2024
Q4 | $544K | Buy |
98,106
+24,033
| +32% | +$133K | 0.01% | 590 |
|
|
2024
Q3 | $618K | Buy |
+74,073
| New | +$618K | 0.01% | 584 |
|
|
2024
Q1 | – | Sell |
-15,469
| Closed | -$100K | – | 863 |
|
|
2023
Q4 | $100K | Buy |
+15,469
| New | +$100K | ﹤0.01% | 777 |
|